Average Co-Inventor Count = 4.38
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Allergan, Inc. (6 from 2,285 patents)
2. Epi Health, LLC (2 from 3 patents)
3. Aclaris Therapeutics, Inc. (1 from 20 patents)
4. Mayne Pharma LLC (1 from 8 patents)
10 patents:
1. 12350255 - Stabilized oxymetazoline formulations and their uses
2. 11517560 - Stabilized oxymetazoline formulations and their uses
3. 10751325 - Stabilized oxymetazoline formulations and their uses
4. 10383942 - Retinoid topical compositions and methods for treating skin conditions
5. 10335391 - Stabilized oxymetazoline formulations and their uses
6. 9974773 - Stabilized oxymetazoline formulations and their uses
7. 9801857 - Stabilized oxymetazoline formulations and their uses
8. 9226931 - Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
9. 9216183 - Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
10. 8758733 - Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists